Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice

Journal of Immunology

Volumn 161, Issue 4, 1998, Pages 1659-1663

  Dai, Zhenhua ^a   Konieczny, Bogumila T ^a   Baddoura, Fady K ^b   Lakkis, Fadi G ^a  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2;

ALLOGRAFT; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; IMMUNE DEFICIENCY; IMMUNOREGULATION; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; CORONARY CIRCULATION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERLEUKIN-2; ISOANTIGENS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, KNOCKOUT; RNA, MESSENGER; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032529195     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Smith, K. A. 1988. Interleukin-2: inception, impact, and implications. Science 240:1169.
2. Kroemer, G., J. L. Andreu, J. A. Gonzalo, J. C. Gutierrez-Ramos, and C. Martinez. 1991. Interleukin-2, autotolerance, and autoimmunity. Adv. Immunol. 50:147.
3. Taniguchi, T., and Y. Minami. 1993. The IL-2/IL-2 receptor system: a current overview. Cell 73:5.
4. Theze, J., P. M. Alzari, and J. Bertoglio. 1996. Interleukin 2 and its receptors: recent advances and new immunological functions, Immunol. Today 17:481.
5. Horak, I., J. Lohler, A. Ma, and K. A. Smith. 1995. Interleukin-2-deficient mice: a new model to study autoimmunity and self-tolerance, Immunol. Rev. 148:35.
6. Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2-deficient by gene targeting. Nature 352:621.
7. Kundig, T. M., H. Schorle, M. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science 262: 1059.
8. Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor α-chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
9. Suzuki, H., T. M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. L. Simard, P. S. Ohashi, H. Griesser, T. Taniguchi, C. J. Paige, and T. W. Mak. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268:1472.
10. + T cells. Eur. J. Immunol. 25:3053.
11. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253.
12. Lenardo, M. J. 1991. Interleukin-2 programs mouse α/β T lymphocytes for apoptosis. Nature 353:858.
13. Boehme, S. A., and M. J. Lenardo. 1993. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur. J. Immunol. 23:1552.
14. Critchfield, J. M., M. K. Racke, J. C. Zuniga-Pflucker, B. Cannella, C. S. Raine, J. Goverman, and M. J. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139.
15. Kneitz, B., T. Herman, S. Yonehara, and A. Schimpl. 1995. Normal clonal expansion but impaired Fas-mediated cell death and anergy in IL-2-deficient mice. Eur. J. Immunol. 25:2572.
16. Van Parijs, L., A. Biuckians, A. Ibragimov, F. W. Alt, D. M. Willerford, and A. K. Abbas. 1997. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158:3738.
17. Steiger, B., P. W. Nickerson, W. Steurer, M. Moscovitch-Lopatin, and T. B. Strom. 1995. IL-2 knockout recipient mice reject islet cell allografts. J. Immunol. 155:489.
18. Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792.
19. Lin, H., S. F. Boiling, P. S. Linsley, R.-Q. Wei, D. Gordon, C. B. Thompson, and L. A. Turka. 1993. Long-term acceptance of major histocompatibility complexmismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp. Med. 178:1801.
20. Pearson, T. C., D. Z. Alexander, K. J. Winn, P. S. Linsley, R. P. Lowry, and C. P. Larsen. 1994. Transplantation tolerance induced by CTLA4-Ig. Transplantation 57:1701.
21. Sayegh, M. H., E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, P. S. Linsley, and L. A. Turka. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181:1869.
22. Corry, R. J., H. J. Winn, and P. S. Russel. 1973. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens. Transplantation 16:343.
23. Hathcock, K. S. 1994. Isolation of mouse mononuclear cells. In Current Protocols in Immunology. J. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley and Sons, New York, p. 3.1.1.
24. Wunderlich, J., and G. Shearer. 1991. Induction and measurement of cytotoxic T lymphocyte activity. In Current Protocols in Immunology. J. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley and Sons, New York, p. 3.11.1.
25. Biddison, W. E., R. Lichtenfels, M. Adibzadeh, and R. Martin. 1994. Measurement of CTL activity by the calcein release assay. In Current Protocols in Immunolog. J. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley and Sons, New York, p. 7.17.4.
26. Billingham, M. E., N. R. B. Cary, M. E. Hammond, J. Kemnitz, C. Marboe, H. A. McCallister, D. C. Snovar, G. L. Winters, and A. Zerbe. 1990. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J. Heart Transplant. 9:587.
27. Kingston, R. E. 1994. Guanidinium method for total RNA preparation. In Current Protocols in Immunology. J. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley and Sons, New York, p. 10.11.5.
28. Takeuchi, T., R. P. Lowry, and B. Konieczny. 1992. Heart allografts in murine systems. Transplantation 53:1281.
29. Tough, D. F., and J. Sprent. 1996. Measurement of T and B cell turnover with bromodeoxyuridine. In Current Protocols in Immunology. J. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley and Sons, New York, p. 4.7.1-4.7.6.
30. Lakkis, F. G., B. T. Konieczny, S. Saleem, F. K. Baddoura, P. S. Linsley, D. Z. Alexander, R. P. Lowry, T. C. Pearson, and C. P. Larsen. 1997. Blocking the CD28-B7 T cell costimulation pathway induces long-term cardiac allograft acceptance in the absence of IL-4. J. Immunol. 158:2443.
31. Linsley, P. S., J. L. Greene, P. Tan, J. Bradshaw, J. A. Ledbetter, C. Anasetti, and N. K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595.
32. Walunas, T. L., C. Y. Bakker, and J. A. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541.
33. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
34. Perez, V. L., L. Van Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
35. Schwartz, R. H. 1996. Models of T cell anergy: is there a common molecular mechanism? J Exp. Med. 184:1.
36. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, K. J. Winn, and T. C. Pearson. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434.
37. Lu, L., S. Qian, P. A. Hershberger, W. A. Rudert, D. H. Lynch, and A. W. Thompson. 1997. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J. Immunol. 158:5676.
38. Van Parijs, L., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
39. Andersson, J., S. Nagy, C. G. Groth, and U. Andersson. 1992. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 75:136.
40. Konieczny, B. T., Z. Dai, E. T. Elwood, S. Saleem, P. Linsley, F. K. Baddoura, C. P. Larsen, T. C. Pearson, and F. G. Lakkis. 1998. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40L T cell co-stimulation pathways. J. Immunol. 160:2059.